Quarantine requirements for the importation of black rhinoceros from Zimbabwe into Australia

SUMMARY The proposal by the Zoological Parks Board of New South Wales to import 10 southern black rhinoceros (Diceros bicornis) from Zimbabwe as part of an international project for conservation of the species presented the Australian Quarantine and Inspection Service (AQIS) with a unique challenge. This importation is, at least in the modern era, the first importation of live herbivores from the African continent. Many of the serious animal diseases in the world are endemic in parts of Africa. Knowledge of which of these diseases infect wild species and may be transmitted from the wild species to domesticated species, is limited. This paper describes the strategies adopted by AQIS to facilitate the importation of rhinoceros while maintaining protection of Australian consumers, rural industries, domestic livestock and fauna against the entry and spread of unwanted pests and diseases.     

In vitro susceptibility of Brachyspira hyodysenteriae to organic acids and essential oil components

The antibacterial potential of organic acids and essential oil components against Brachyspira hyodysenteriae, the causative pathogen of swine dysentery, was evaluated. Minimum inhibitory concentrations (MIC) of 15 compounds were determined at pH 7.2 and pH 6.0, using a broth microdilution assay. In addition, possible synergism was determined. MIC values for the three tested strains were similar. For organic acids, MIC values at pH 6.0 were lower than at pH 7.2. B. hyodysenteriae was most sensitive to cinnamaldehyde and lauric acid, with MIC values <1.5 mM. Most antibacterial effects of binary combinations were additive, however, for thymol and carvacrol, synergism could be observed. In vitro results demonstrate the antibacterial action of certain essential oil components and organic acids against B. hyodysenteriae.     

Association between weight change during initial chemotherapy and clinical outcome in dogs with multicentric lymphoma

The majority of the known prognostic factors in dogs with lymphoma have been evaluated before treatment commences or at the time of diagnosis. Prognostic factors evaluated during the initial phase of treatment are less described but may provide important clinical information. In this retrospective study, 82 canine lymphoma patients were categorized according to the weight change between diagnosis and after 5 weeks of chemotherapy. Dogs that gained greater than 5% or lost greater than 5% of initial body weight were categorized as increased‐ or decreased‐weight groups, respectively. Those in which weight changed less than 5% were categorized as the maintained‐weight group. The median progression‐free survival (PFS) in the increased‐weight group, maintained‐weight group and decreased‐weight group was 226, 256 and 129 days, respectively. The decreased‐weight group had significantly shorter PFS than the increased and maintained groups (P = .023, P = .003, respectively). The median survival time (ST) in the increased‐weight group, maintained‐weight group and decreased‐weight group was 320, 339 and 222 days, respectively. There was no significant difference in ST among the three groups (P = .128). In Cox‐regression results, weight change group and initial body weight were significant risk factors associated to PFS (P = .007, P = .001, respectively) while only patient's initial body weight was a significant risk factor to ST (P = .013). In conclusion, evaluation of initial body weight and weight changes over time can provide valuable information regarding PFS and ST in dogs with multicentric lymphoma.     

Nanosize of zinc oxide and the effects on zinc digestibility,growth performances,immune response and serum parameters of weanling piglets

The aim of this study was to investigate the effect of dietary supplementation of nanosize zinc on zinc digestibility, growth performances, immune response and serum parameters of weanling piglets. Ninety‐six LYD weanling piglets were assigned to control, zinc oxide (ZnO), organic‐Zn (Zn‐methionine) and nanosize ZnO (nano‐Zn) groups with four replicates. The zinc was at the 120 mg/kg level in the treatment group's diet, while the control group's was 80 mg/kg Zn. The experiment results indicated that the nano‐Zn and organic‐Zn groups had significantly higher Zn digestibility compared to the ZnO and control groups. For the immune response traits, the IgG level and goat red blood cells (GRBC) antibody titer were nano‐Zn and organic‐Zn>ZnO>control; in the phytohemagglutinin (PHA) challenge test result, nano‐Zn>organic‐Zn>ZnO>control; in regard to the γ‐globulin level, nano‐Zn and organic‐Zn>ZnO and control, with significant difference between groups. In the serum parameters aspect, serum Zn concentration in nano‐Zn and organic‐Zn groups were higher than in the ZnO and control groups, serum growth hormone concentration was increased in the nano‐Zn group than in the other groups. In conclusion, nanosize zinc oxide for dietary supplementation can increase zinc digestibility, serum growth hormone levels and carbonic anhydrase activity and enhance the immune response of weanling piglets.     

Retrospective assessment of tolerability and efficacy of zoledronate in the palliative treatment of cancer-bearing dogs

Zoledronate is a bisphosphonate frequently used for the treatment of hypercalcaemia of malignancy and tumour-associated bone pain in dogs, however, there is a paucity of information regarding its use in veterinary medicine. The aim of this retrospective study was to report the tolerability of zoledronate in the palliative treatment of cancer-bearing dogs and secondarily to to assess the efficacy of zoledronate for the treatment of hypercalcaemia of malignancy. Thirty-seven dogs (22 with tumour-associated bone pain and 15 with hypercalcaemia of malignancy) that received 114 zoledronate infusions were included. Tolerability was assessed by the absence of post-zoledronate hypocalcaemia or other adverse events as defined by Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events criteria. Efficacy was assessed by comparison of available ionized calcium levels before and after zoledronate administration in hypercalcaemic dogs. In 79% of zoledronate infusions, no adverse events were reported. The majority of adverse events which occurred in the other 21% of infusions could be attributed to concurrent chemotherapy or the underlying neoplastic disease. There was a small but significant increase in creatinine following treatment with zoledronate, however, none of the dogs developed clinically significant renal disease. In eight hypercalcaemic dogs with available ionized calcium following zoledronate administration, ionized calcium decreased rapidly within 7 days following treatment with zoledronate. Zoledronate is well-tolerated with few recorded adverse events, however, monitoring of serum creatinine is advised. Zoledronate seems to be effective in the treatment of hypercalcaemia of malignancy.     

新疆生产建设兵团第八师农田残膜含量及在土壤中分布情况

在新疆生产建设兵团第八师农田进行了残膜样品采集,并对不同采样深度下不同面积的农田残膜含量及数量进行统计分析,获取了土壤中残膜的分布情况,旨在为残膜回收机械的设计以及残膜回收策略的制定提供参考。      

放牧补饲对肉用犊牛生长发育与经济效益的影响

[目的]研究在放牧补饲条件下不同品种肉牛的早期生长发育与经济效益。[方法]选择3月龄断奶新褐杂牛(新疆褐牛与本地牛)、安杂牛(安格斯与本地牛)、荷斯坦牛、土种牛31头,按品种分组开展夏草场放牧补饲试验。[结果]安杂牛、荷斯坦牛、新褐杂牛和土种牛补饲日增重分别为0.51、0.55、0.56、0.25 kg/d,安杂牛、荷斯坦牛、新褐杂牛的日增重与土种牛相比差异极显著(P0.01)。新褐杂牛、荷斯坦牛、安杂牛的放牧补饲效果较土种牛好,新褐杂牛、荷斯坦牛、安杂牛和土种牛的投入产出比分别为1∶2.32、1∶2.29、1∶2.12和1∶1.02,放牧补饲经济效益明显。[结论]早期断奶对后期放牧补饲肉牛的生长发育具有促进作用。     

水生植被对洪泽湖湖滨湿地水环境净化效果及影响因素分析(英文)

[目的]分析研究洪泽湖湖滨地区植物群落对湿地水环境的净化效果,为该区生态修复提供参考依据。[方法]以洪泽湖湿地国家级自然保护区典型湖滨带为研究对象,通过对该区的水草区和无草区环境特征进行野外调查,并结合室内试验,测定湖泊湿地水体的营养盐(N和P)、化学需氧量(COD)及透明度(SD)含量的变化,定量分析水生植被在生长过程中对湖泊湿地生态系统中水环境的净化效果,并对其可能存在的影响因素进行探讨。[结果]水生植被对洪泽湖湿地水环境中TN、TP、COD、Chla的去除作用及对SD含量变化有较明显的影响。水生植物之间的竞争可以抑制藻类的生长,减轻水体的富营养化情况。[结论]该试验为研究洪泽湖湖滨带生态修复及增强其自净能力提供理论依据。     

Effects of chromium nicotinate on performance, carcase characteristics and blood chemistry of growing turkeys

1. The objective of this trial was to study the effects of chromium nicotinate (Cr) supplementation on the performance, carcase characteristics and blood constituents of 9 to 22 week-old male turkeys. 2. Fifty-four 8-week-old male turkeys weighing 2.9 +/- 0.28 kg were allocated at random into 9 groups with 3 dietary treatments and 3 replicates. The dietary treatment was different dietary concentrations of chromium in the basal diet, to provide 0 (control), 1 or 3 mg/kg. The feeding trial lasted for 14 weeks. 3. Results showed that 1 mg/kg chromium supplementation significantly improved weight gain and food intake at 9 to 18 weeks of age but did not significantly influence performance at 19 to 22 week of age. The breast and thigh muscle were significantly increased in birds receiving 1 mg/kg chromium supplementation but were decreased by 3 mg/kg of supplementation. 4. Dietary chromium supplementation did not significantly influence other serum constituents, including insulin, HDL, VLDL+LDL, HDL-C, VLDL-C+LDL-C, total protein, albumin, and gamma-globulin at 18 and 22 weeks of age. 5. The serum triacylglycerol (TG) and uric acid contents were significantly increased, while glycerol and alpha-globulin were significantly reduced by 3 mg/kg chromium supplementation. However, 1 mg/kg chromium supplementation significantly reduced serum cholesterol and glycerol at 18-weeks old. At 22 weeks of age, 1 mg/kg chromium supplementation significantly increased serum glucose and decreased the uric acid concentration whereas 3 mg/kg chromium supplementation significantly increased the creatinine concentration and decreased beta-globulin concentration.